KHK7580
Sponsors
Kyowa Kirin Co., Ltd.
Conditions
HyperparathyroidismParathyroid CarcinomaPrimary HyperparathyroidismSecondary Hyperparathyroidism
Phase 1
Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
CompletedNCT01935856
Start: 2013-08-31End: 2014-03-31Updated: 2017-03-03
Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis
CompletedNCT02143271
Start: 2014-05-31End: 2014-12-31Updated: 2015-03-05
Phase 2
Phase 3
Phase 3 Study of KHK7580
CompletedNCT02549417
Start: 2015-09-29End: 2016-12-22Updated: 2017-07-05
Phase 3 Study of KHK7580
CompletedNCT02549404
Start: 2015-09-28End: 2016-12-28Updated: 2017-07-05
Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
CompletedNCT03280264
Start: 2017-08-30End: 2019-04-09Updated: 2021-05-27
Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia
CompletedNCT03822507
Start: 2019-04-09End: 2021-09-23Updated: 2022-04-25